About eXmoor
eXmoor is a company based in Bristol (United Kingdom) founded in 2004. eXmoor has raised $51.75 million across 2 funding rounds from investors including MVM Partners and Kineticos. eXmoor offers products and services including Process Development, GMP Manufacture, Fill and Finish, and QP Release. eXmoor operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
- Headquarter Bristol, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Exmoor Pharma Concepts Limited
- Date of Incorporation 03 Mar, 2004
- Jurisdiction TAUNTON, SOMERSET, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$51.75 M (USD)
in 2 rounds
-
Latest Funding Round
$35 M (USD), Series A
May 30, 2023
-
Investors
MVM Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eXmoor
eXmoor offers a comprehensive portfolio of products and services, including Process Development, GMP Manufacture, Fill and Finish, and QP Release.
Early stage support for therapy development and scale-up
Production of viral vectors and cell therapies
Final packaging and quality release of therapies
Certification for regulatory compliance in therapies
People of eXmoor
Unlock access to complete
Funding Insights of eXmoor
eXmoor has successfully raised a total of $51.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $35 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in eXmoor
eXmoor has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include MVM Partners and Kineticos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in healthcare companies are managed.
|
Locked | Locked | Locked | |
|
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
Locked | Locked | Locked |
Investor details for eXmoor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eXmoor
Investment portfolio details for eXmoor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - eXmoor
Detailed financials for eXmoor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exmoor Comparisons
Peer comparison for eXmoor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of eXmoor
eXmoor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell and gene therapies for multiple disorders are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for the biopharma sector.
|
|
| Locked | Locked | Locked |
Services for cell therapy development and manufacturing are provided.
|
|
| Locked | Locked | Locked |
Development and manufacturing services for cell-based therapies are provided.
|
|
| Locked | Locked | Locked |
Stem cell-based therapy services for research solutions are provided.
|
|
| Locked | Locked | Locked |
A biotechnology company focused on anti-aging therapeutics development.
|
Detailed competitors of eXmoor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exmoor
Complete news archive for eXmoor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about eXmoor
eXmoor was founded in 2004 and raised its 1st funding round 17 years after it was founded.
eXmoor is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.
eXmoor is a funded company, having raised a total of $51.75M across 2 funding rounds to date.
eXmoor was founded in 2004 and is based in Bristol, United Kingdom. Cell and gene therapeutic services are delivered by the company to support the biopharmaceutical sector. Operations encompass development and manufacturing processes for advanced therapies. Focus is placed on regulatory compliance and scalable solutions for client needs in the United Kingdom and beyond. Expertise is applied to streamline therapeutic pipelines for pharmaceutical partners.
eXmoor's top competitors include Ori Biotech, MaSTherCell and OBiO Technology.
eXmoor offers Process Development, GMP Manufacture, Fill and Finish, and QP Release.
eXmoor has 2 investors. Key investors include MVM Partners, and Kineticos.